Attractive outlook for global biotech stocks

Global biotechnology stocks provide serious upside potential for investors willing to commit their funds long-term, according to fund managers in the sector. Still sitting on cash after the equity-raising frenzy of 1999-2000, biotechnology drug researchers have the resources to develop their product offerings without needing to solicit handouts from larger corporates. M&G Global Health fund manager Marjan Daeipour says: 'The long-term outlook for the sector remains positive ' biotechnology continues to be a key source of products for the healthcare industry, including the pharmaceutica...